Maria Agemark
Director/Board Member en GFM Förvaltning AB .
Perfil
Maria Agemark is currently a Director at GFM Förvaltning AB.
Previously, she worked as a Deputy Director at ApoGlyx AB and as a Chief Operating Officer at SenzaGen AB from 2015 to 2021.
She has an undergraduate and doctorate degree from the University of Lund.
Cargos activos de Maria Agemark
| Empresas | Cargo | Inicio |
|---|---|---|
| GFM Förvaltning AB | Director/Board Member | - |
Antiguos cargos conocidos de Maria Agemark.
| Empresas | Cargo | Fin |
|---|---|---|
| SENZAGEN AB | Chief Operating Officer | 01/03/2015 |
ApoGlyx AB
 ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden. | Corporate Officer/Principal | - |
Formación de Maria Agemark.
| University of Lund | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SENZAGEN AB | Health Technology |
| Empresas privadas | 2 |
|---|---|
ApoGlyx AB
ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden. | Health Technology |
| GFM Förvaltning AB |
- Bolsa de valores
- Insiders
- Maria Agemark
